Pirfenidone Viatris 유럽 연합 - 리투아니아어 - EMA (European Medicines Agency)

pirfenidone viatris

viatris limited - pirfenidone - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - imunosupresantai - pirfenidone viatris is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).

Dutasteride/Tamsulosin Viatris [Dutasteride/Tamsulosin Mylan] 리투아니아 - 리투아니아어 - SMCA (Valstybinė vaistų kontrolės tarnyba)

dutasteride/tamsulosin viatris [dutasteride/tamsulosin mylan]

viatris limited - dutasteridas/tamsulozino hidrochloridas - kietosios kapsulės - 0,5 mg/0,4 mg - tamsulosin and dutasteride

Tiotropium bromide Viatris [Tiotropium bromide Mylan] 리투아니아 - 리투아니아어 - SMCA (Valstybinė vaistų kontrolės tarnyba)

tiotropium bromide viatris [tiotropium bromide mylan]

viatris limited - tiotropis - įkvepiamieji milteliai (kietosios kapsulės) - 18 µg - tiotropium bromide

Dapagliflozin Viatris 유럽 연합 - 리투아니아어 - EMA (European Medicines Agency)

dapagliflozin viatris

viatris limited - dapagliflozin - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - narkotikai, vartojami diabetu - type 2 diabetes mellitusdapagliflozin viatris is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance. - in addition to other medicinal products for the treatment of type 2 diabetes. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 ir 5. heart failuredapagliflozin viatris is indicated in adults for the treatment of symptomatic chronic heart failure with reduced ejection fraction. chronic kidney diseasedapagliflozin viatris is indicated in adults for the treatment of chronic kidney disease.

Clopidogrel Viatris (previously Clopidogrel Taw Pharma) 유럽 연합 - 리투아니아어 - EMA (European Medicines Agency)

clopidogrel viatris (previously clopidogrel taw pharma)

viatris limited - klopidogrelio besilatas - peripheral vascular diseases; stroke; myocardial infarction - antitromboziniai vaistai - secondary prevention of atherothrombotic events clopidogrel is indicated in:adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. adult patients suffering from acute coronary syndrome. non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). st segmento pakilimu ūmus miokardo infarktas, kartu su asr medikamentais gydytų pacientų, atitinkančių trombolizinė terapija. in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is) clopidogrel in combination with asa is indicated in:adult patients with moderate to high-risk tia (abcd2 score ≥4) or minor is (nihss ≤3) within 24 hours of either the tia or is event. prevention of atherothrombotic and thromboembolic events in atrial fibrillation:in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. daugiau informacijos, skaitykite skyrių 5.

Kreon 25000 V 리투아니아 - 리투아니아어 - SMCA (Valstybinė vaistų kontrolės tarnyba)

kreon 25000 v

viatris healthcare limited - kasos milteliai (lipazė/amilazė/proteazė) - skrandyje neirios kietosios kapsulės - 400 mg (40000 v/25000 v/1600 v); 300 mg (25000 v/18000 v/1000 v); 150 mg (10000 v/8000 v/600 v); 18000 v/25000 v/1000 v; 10000 v - multienzymes (lipase, protease etc.)

Pemetrexed Viatris [Pemetrexed Mylan] 리투아니아 - 리투아니아어 - SMCA (Valstybinė vaistų kontrolės tarnyba)

pemetrexed viatris [pemetrexed mylan]

viatris limited - pemetreksedas - koncentratas infuziniam tirpalui - 25 mg/ml - pemetrexed

Amitriptylinum Viatris [Amitriptylinum MEDA] 리투아니아 - 리투아니아어 - SMCA (Valstybinė vaistų kontrolės tarnyba)

amitriptylinum viatris [amitriptylinum meda]

viatris healthcare limited - amitriptilinas - dengtos tabletės - 25 mg; 10 mg - amitriptyline